Bio Protocol Launches Aubrai, the First Decentralized AI for Longevity!

Jakarta, Pintu News – The world of scientific research welcomes a new era with the launch of Aubrai, the first decentralized AI agent focused on longevity science. The project, developed by Bio Protocol and VitaDAO, aims to address financing challenges in scientific research by utilizing blockchain technology.

Aubrai not only accelerates the process of scientific discovery but also offers a new model for the financing and distribution of profits from scientific discovery.

Aubrai’s Innovation in Longevity Research

Aubrai, launched on the Base platform, is a collaboration between Bio Protocol and VitaDAO with support from the Aubrey de Grey LEV Foundation. This AI agent is designed to integrate proprietary data from Aubrey de Grey’s laboratory, which has not yet been published, giving it an edge in generating new commercially relevant hypotheses in longevity science.

Read also: MANTRA Launches First RWA Product Organized with Pyse Earth Electric Bike Fleet!

Using blockchain technology, Aubrai enables transparency and efficiency in credit attribution and experiment financing. Aubrai turns research results into tokenized assets, enabling laboratories to finance themselves through market mechanisms other than philanthropy or traditional capital markets.

The AUBRAI token grants its holders permanent ownership rights to research results, rights in funding decisions, and revenue sharing from commercialized inventions. This opens up new avenues for researchers to secure funding and commercialize their inventions.

Impact and Potential of Aubrai

Aubrai has demonstrated its capabilities in the Robust Mouse Rejuvenation (RMR2) study, which is one of the largest mouse longevity experiments ever attempted. It has suggested methodology adjustments and identified dosing warnings that were previously only discovered after weeks of manual review.

Aubrai’s presence has been transformational, accelerating the process of discovery and experimental validation. In addition, Aubrai facilitates the creation of IP-tokens that can be licensed to pharmaceutical or biotech companies, with revenue returned to researchers and contributors.

This approach not only accelerates the research process but also democratizes research outcomes, allowing for a more equitable and transparent distribution of benefits to all parties involved.

Read also: Tom Lee Predicts Ethereum Price Can Quickly Recover, BitMine Buys $21 Million ETH!

Challenges and Future of DeSci

Although Aubrai shows great potential, DeSci projects like this may face regulatory challenges and skepticism from established pharmaceutical companies.

Tokenized intellectual property, which is a core part of the Aubrai model, may attract the attention of regulators and require careful legal navigation. However, it also marks an important step in the evolution of the way science is organized and financed.

On the other hand, if successful, Aubrai could prove that blockchain has potential for more than just creating the next meme coin. It could provide the necessary infrastructure to accelerate research itself, pushing the field of longevity closer to therapies that extend the span of human health.

Furthermore, these developments will also signal that decentralized science can serve as a viable market alternative to funding structures that have long constrained biomedical innovation.

That’s the latest information about crypto. Follow us on Google News to get the latest crypto news about crypto projects and blockchain technology. Also, learn crypto from scratch with complete discussion through Pintu Academy and stay up-to-date with the latest crypto market such as bitcoin price today, xrp coin price today, dogecoin and other crypto asset prices through Pintu Market.

Enjoy an easy and secure crypto trading experience by downloading Pintu crypto app via Google Play Store or App Store now. Also, get a web trading experience with various advanced trading tools such as pro charting, various types of order types, and portfolio tracker only at Pintu Pro.

*Disclaimer

This content aims to enrich readers’ information. Pintu collects this information from various relevant sources and is not influenced by outside parties. Note that an asset’s past performance does not determine its projected future performance. Trading crypto carries high risk and volatility, always do your own research and use cold hard cash before investing. All activities of buying and selling bitcoin and other crypto asset investments are the responsibility of the reader.

Reference:

• Coindesk. Decentralized Science Project Aubrai Launches on Base to Tackle Science Funding’s ‘Valley of Death’. Accessed on August 27, 2025
• Crypto News. Bio-Protocol Launches Aubrai, the First-Ever Decentralized AI Agent for Longevity Science. Accessed on August 27, 2025